Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2
Layale Yaghi, Isabelle Poras, Renata Toscano Simões, et al.
Oncotarget (2016) Vol. 7, Iss. 39, pp. 63690-63707
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Regulation of immunity and inflammation by hypoxia in immunological niches
Cormac T. Taylor, Sean P. Colgan
Nature reviews. Immunology (2017) Vol. 17, Iss. 12, pp. 774-785
Open Access | Times Cited: 540
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Carla Riera‐Domingo, Annette Audigé, Sara Granja, et al.
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 1-102
Open Access | Times Cited: 251
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
Bin Wang, Qin Zhao, Yuyu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 218
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma
Qianquan Ma, Wenyong Long, Changsheng Xing, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 198
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
Muhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1083-1083
Open Access | Times Cited: 178
Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
Yiliang Li, Sapna P. Patel, Jason Roszik, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 174
Deregulation of HLA-I in cancer and its central importance for immunotherapy
Ahmet Hazini, Kerry Fisher, Leonard W. Seymour
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002899-e002899
Open Access | Times Cited: 138
Hypoxia-inducible factors and innate immunity in liver cancer
Vincent Wai‐Hin Yuen, Carmen Chak‐Lui Wong
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5052-5062
Open Access | Times Cited: 137
Hypoxia and HIF pathway in cancer and the placenta
Philip S. Macklin, James McAuliffe, Christopher W. Pugh, et al.
Placenta (2017) Vol. 56, pp. 8-13
Open Access | Times Cited: 102
Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints
Audrey Lequeux, Muhammad Zaeem Noman, Malina Xiao, et al.
Cancer Letters (2019) Vol. 458, pp. 13-20
Open Access | Times Cited: 94
Characteristics of the Tumor Microenvironment That Influence Immune Cell Functions: Hypoxia, Oxidative Stress, Metabolic Alterations
Ryan C. Augustin, Greg M. Delgoffe, Yana G. Najjar
Cancers (2020) Vol. 12, Iss. 12, pp. 3802-3802
Open Access | Times Cited: 84
Hypoxia and the phenomenon of immune exclusion
Violena Pietrobon, Francesco M. Marincola
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 84
Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage
Ahmad Syukri, Budu Budu, Mochammad Hatta, et al.
Annals of Medicine and Surgery (2022) Vol. 76
Open Access | Times Cited: 40
HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment
Rindert Missiaen, Nicholas P. Lesner, M. Celeste Simon
The EMBO Journal (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 33
Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors
Franziska Eckert, Kerstin Zwirner, Simon Boeke, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 55
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30
Natural killer cells in cancer immunotherapy
Danru Wang, LingYun Dou, Lihao Sui, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 6
A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy
Wafa Bouleftour, Elise Rowinski, Safa Louati, et al.
Medical Science Monitor (2021) Vol. 27
Open Access | Times Cited: 40
Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5
Association of HLA-Ib (HLA-G, HLA-E and HLA-F) with spontaneous HBV clearance
Ahmed Baligh Laaribi, Asma Mehri, H Chaouch, et al.
Infectious Diseases (2025), pp. 1-11
Closed Access
Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells
Marica Garziera, Lucia Scarabel, Giuseppe Toffoli
Journal of Immunology Research (2017) Vol. 2017, pp. 1-13
Open Access | Times Cited: 47
Haplotypes of the HLA-G 3’ Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially
Isabelle Poras, Layale Yaghi, Gustavo Martelli‐Palomino, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169032-e0169032
Open Access | Times Cited: 43
Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line
Francesco Paolo Cammarata, Filippo Torrisi, Giusi Irma Forte, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4745-4745
Open Access | Times Cited: 36
Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications
Daniel Desaulniers, Paule Vasseur, Abigail Jacobs, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 10969-10969
Open Access | Times Cited: 32
Human leukocyte antigen-G in hepatocellular carcinoma driven by chronic viral hepatitis or steatotic liver disease
Stefano Mocci, Andrea Perra, Roberto Littera, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top